Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.920
-0.240 (-7.59%)
At close: Jan 21, 2025, 4:00 PM
2.900
-0.020 (-0.68%)
After-hours: Jan 21, 2025, 7:54 PM EST
Sana Biotechnology Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
328
Market Cap
651.95M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
SANA News
- 11 days ago - Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 13 days ago - Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 13 days ago - Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success - Seeking Alpha
- 13 days ago - Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why - Benzinga
- 13 days ago - This Biotech Stock Just Soared 240%. Why It Can Go Higher. - Barrons
- 14 days ago - Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewsWire
- 6 weeks ago - Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus - Seeking Alpha
- 2 months ago - Sana Biotechnology to Present at December 2024 Investor Conferences - GlobeNewsWire